Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,155,525
+$647,282 QoQ
Shares Held
55,737
+0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#919
of 4,663 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OSTRUM ASSET MANAGEMENT holds $119,909,621 across 9 Drug Manufacturers - General names. JNJ ranks #2 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
72,402 | $86,841,138 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
55,737 | $14,155,525 | |
| 3 | ABBV |
AbbVie Inc.
|
30,320 | $7,629,724 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
61,627 | $3,550,947 | |
| 5 | PFE |
Pfizer Inc
|
119,911 | $2,887,456 | |
| 6 | MRK |
Merck & Co., Inc.
|
19,140 | $2,459,490 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
8,670 | $1,095,367 | |
| 8 | AMGN |
Amgen Inc
|
2,508 | $908,196 |
All Filings in JNJ
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,155,525 | 55,737 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $13,508,243 | 55,262 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $14,810,169 | 71,564 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $13,513,409 | 72,880 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $13,484,617 | 88,279 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $14,241,344 | 85,874 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $12,252,929 | 84,725 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $12,690,594 | 78,308 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $11,596,334 | 79,340 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,787,925 | 68,196 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $10,912,709 | 69,623 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $9,631,891 | 61,842 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,677,364 | 64,508 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,891,170 | 63,814 | Shares | Defined | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||